Could shortwaves soothe diabetic nerve pain?
NCT ID NCT07625007
First seen Jun 05, 2026 · Last updated Jun 23, 2026 · Updated 4 times
Summary
This study tests whether shortwave therapy can relieve symptoms of diabetic peripheral neuropathy, a common complication causing pain, numbness, and tingling. Researchers will enroll 202 adults and randomly assign them to receive either real shortwave treatment or a sham (fake) device for 20 minutes daily over five days. The main goal is to see if symptoms improve one month later, measured by a standard neuropathy score.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC PERIPHERAL NEUROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Shortwave diathermy device
What this could lead to
If it works, this could offer a drug-free option to reduce pain and numbness from diabetic nerve damage.
What could go wrong
This is a small, early-stage trial with no phase. The treatment is short (5 days) and may not provide lasting relief. The sham control helps but results may not apply to everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.